Although hepatotoxicity has been described with virtually all drugs, DILI represents less than 1% of cases of acute liver injury. An incidence of 13.9 to 19.1 cases per 100,000 inhabitants has been reported 3 . In a broad review of DILI published series, the authors found that 34.2% of cases of suspected DILI had alternative causes of liver injury that confound the DILI diagnosis. They suggest that DILI diagnosis should be established using a score system such as the RUCAM/CIOMS scale 4 . Although this scale has its limitations, it can sometimes help establish the causality in DILI. In the case of our patient, other causes of liver injury were excluded and the RUCAM/CIOMS scale indicated a causality level of probable in both episodes.
Susceptibility to DILI is believed to be the result from interplay of multiple factors, including those related to the structure of the drug, patient's genetic background, the influence of underlying diseases, and associated medications 5 . Nevertheless, a genetic base of DILI has not been determined 
